Xiaoying Li

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 08, 2025
E3 ligase Skp2-mediated stabilization of survivin contributes to radioresistance.

Shiming Tan, Ruirui Wang, Jinglin Fang

|May 25, 2024
Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer.

Yi-Fu He, Yi-Ping Liu, Jin-Zhuang Liao

|Feb 22, 2023
Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway.

Xiaoying Li, Li Zhou, Ruike Wang

|Feb 10, 2023
TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance.

Xin Dong, Xiaoying Li, Yu Gan

|Jan 18, 2023
Correction to: Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.

Ming Li, Feng Gao, Xiaoying Li

|Dec 19, 2022
Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.

Ming Li, Feng Gao, Xiaoying Li

Pageof 2